-->
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 OBJECTIVES OF THE STUDY
2.2 STAKEHOLDERS
2.3 DATA SOURCES
2.3.1 PRIMARY SOURCES
2.3.2 SECONDARY SOURCES
2.4 MARKET ESTIMATION
2.4.1 BOTTOM-UP APPROACH
2.4.2 TOP-DOWN APPROACH
2.5 FORECASTING METHODOLOGY
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 OVERVIEW
4.2 KEY INDUSTRY TRENDS
5 GLOBAL STROKE MANAGEMENT MARKET
5.1 MARKET OVERVIEW
5.2 MARKET PERFORMANCE
5.3 IMPACT OF COVID-19
5.4 MARKET FORECAST
6 MARKET BREAKUP BY TYPE
6.1 DIAGNOSTICS
6.1.1 MARKET TRENDS
6.1.2 KEY SEGMENTS
6.1.2.1 MAGNETIC RESONANCE IMAGING (MRI)
6.1.2.2 CAROTID ULTRASOUND
6.1.2.3 CEREBRAL ANGIOGRAPHY
6.1.2.4 ELECTROCARDIOGRAPHY
6.1.2.5 ECHOCARDIOGRAPHY
6.1.2.6 OTHERS
6.1.3 MARKET FORECAST
6.2 THERAPEUTICS
6.2.1 MARKET TRENDS
6.2.2 KEY SEGMENTS
6.2.2.1 TISSUE PLASMINOGEN ACTIVATOR
6.2.2.2 ANTICOAGULANT
6.2.2.3 ANTIPLATELET
6.2.2.4 ANTIHYPERTENSIVE
6.2.3 MARKET FORECAST
6.3 SOFTWARE
7 MARKET BREAKUP BY APPLICATION
7.1 ISCHEMIC STROKE
7.1.1 MARKET TRENDS
7.1.2 MARKET FORECAST
7.2 HAEMORRHAGIC STROKE
7.2.1 MARKET TRENDS
7.2.2 MARKET FORECAST
7.3 OTHERS
7.3.1 MARKET TRENDS
7.3.2 MARKET FORECAST
9 MARKET BREAKUP BY REGION
9.1 NORTH AMERICA
9.1.1 UNITED STATES
9.1.1.1 MARKET TRENDS
9.1.1.2 MARKET FORECAST
9.1.2 CANADA
9.1.2.1 MARKET TRENDS
9.1.2.2 MARKET FORECAST
9.2 ASIA-PACIFIC
9.2.1 CHINA
9.2.1.1 MARKET TRENDS
9.2.1.2 MARKET FORECAST
9.2.2 JAPAN
9.2.2.1 MARKET TRENDS
9.2.2.2 MARKET FORECAST
9.2.3 INDIA
9.2.3.1 MARKET TRENDS
9.2.3.2 MARKET FORECAST
9.2.4 SOUTH KOREA
9.2.4.1 MARKET TRENDS
9.2.4.2 MARKET FORECAST
9.2.5 AUSTRALIA
9.2.5.1 MARKET TRENDS
9.2.5.2 MARKET FORECAST
9.2.6 INDONESIA
9.2.6.1 MARKET TRENDS
9.2.6.2 MARKET FORECAST
9.2.7 OTHERS
9.2.7.1 MARKET TRENDS
9.2.7.2 MARKET FORECAST
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 MARKET TRENDS
9.3.1.2 MARKET FORECAST
9.3.2 FRANCE
9.3.2.1 MARKET TRENDS
9.3.2.2 MARKET FORECAST
9.3.3 UNITED KINGDOM
9.3.3.1 MARKET TRENDS
9.3.3.2 MARKET FORECAST
9.3.4 ITALY
9.3.4.1 MARKET TRENDS
9.3.4.2 MARKET FORECAST
9.3.5 SPAIN
9.3.5.1 MARKET TRENDS
9.3.5.2 MARKET FORECAST
9.3.6 RUSSIA
9.3.6.1 MARKET TRENDS
9.3.6.2 MARKET FORECAST
9.3.7 OTHERS
9.3.7.1 MARKET TRENDS
9.3.7.2 MARKET FORECAST
9.4 LATIN AMERICA
9.4.1 BRAZIL
9.4.1.1 MARKET TRENDS
9.4.1.2 MARKET FORECAST
9.4.2 MEXICO
9.4.2.1 MARKET TRENDS
9.4.2.2 MARKET FORECAST
9.4.3 OTHERS
9.4.3.1 MARKET TRENDS
9.4.3.2 MARKET FORECAST
9.5 MIDDLE EAST AND AFRICA
9.5.1 MARKET TRENDS
9.5.2 MARKET BREAKUP BY COUNTRY
9.5.3 MARKET FORECAST
10 SWOT ANALYSIS
10.1 OVERVIEW
10.2 STRENGTHS
10.3 WEAKNESSES
10.4 OPPORTUNITIES
10.5 THREATS
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 OVERVIEW
12.2 BARGAINING POWER OF BUYERS
12.3 BARGAINING POWER OF SUPPLIERS
12.4 DEGREE OF COMPETITION
12.5 THREAT OF NEW ENTRANTS
12.6 THREAT OF SUBSTITUTES
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 MARKET STRUCTURE
14.2 KEY PLAYERS
14.3 PROFILES OF KEY PLAYERS
14.3.1 JLK
14.3.1.1 COMPANY OVERVIEW
14.3.1.2 PRODUCT PORTFOLIO
14.3.1.3 FINANCIALS
14.3.1.4 SWOT ANALYSIS
14.3.2 HEURON CO., LTD.
14.3.2.1 COMPANY OVERVIEW
14.3.2.2 PRODUCT PORTFOLIO
14.3.2.3 SWOT ANALYSIS
14.3.3 GENERAL ELECTRIC COMPANY
14.3.3.1 COMPANY OVERVIEW
14.3.3.2 PRODUCT PORTFOLIO
14.3.3.3 FINANCIALS
14.3.3.4 SWOT ANALYSIS
14.3.4 ISCHEMAVIEW, INC.
14.3.4.1 COMPANY OVERVIEW
14.3.4.2 PRODUCT PORTFOLIO
14.3.4.3 FINANCIALS
14.3.4.4 SWOT ANALYSIS
14.3.5 VIZ.AI, INC.
14.3.5.1 COMPANY OVERVIEW
14.3.5.2 PRODUCT PORTFOLIO
14.3.5.3 FINANCIALS
14.3.5.4 SWOT ANALYSIS
14.3.6 MERCK & CO. INC
14.3.6.1 COMPANY OVERVIEW
14.3.6.2 PRODUCT PORTFOLIO
14.3.6.3 FINANCIALS
14.3.6.4 SWOT ANALYSIS
14.3.7 VASSOL INC.
14.3.7.1 COMPANY OVERVIEW
14.3.7.2 PRODUCT PORTFOLIO
14.3.7.3 FINANCIALS
14.3.7.4 SWOT ANALYSIS
14.3.8 AIDOC
14.3.8.1 COMPANY OVERVIEW
14.3.8.2 PRODUCT PORTFOLIO
14.3.8.3 FINANCIALS
14.3.8.4 SWOT ANALYSIS
14.3.9 CARDINAL HEALTH
14.3.9.1 COMPANY OVERVIEW
14.3.9.2 PRODUCT PORTFOLIO
14.3.9.3 FINANCIALS
14.3.9.4 SWOT ANALYSIS
14.3.10 NEURASIGNAL, INC.
14.3.10.1 COMPANY OVERVIEW
14.3.10.2 PRODUCT PORTFOLIO
14.3.10.3 FINANCIALS
14.3.10.4 SWOT ANALYSIS
14.3.11 BRAINOMIX
14.3.12 BRISTOL-MYERS SQUIBB COMPANY
14.3.13 BOSTON SCIENTIFIC CORPORATION
14.3.14 ABBOTT LABORATORIES
14.3.15 METHINKS
14.3.16 QURE.AI
14.3.17 SIEMENS AG
14.3.18 B. BRAUN SE
14.3.19 KONINKLIJKE PHILIPS N.V
14.3.20 DEEPNOID CO., LTD.
14.3.21 MEDTRONIC
著作権 ©2022 無断複写・転載を禁じます